UNUM THERAPEUTICS INC's ticker is UMRX and the CUSIP is 903214104. A total of 48 filers reported holding UNUM THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $1,055,000 | -45.1% | 732,967 | 0.0% | 0.00% | – |
Q2 2019 | $1,920,000 | -40.3% | 732,967 | 0.0% | 0.00% | -100.0% |
Q1 2019 | $3,218,000 | -0.2% | 732,967 | 0.0% | 0.00% | 0.0% |
Q4 2018 | $3,225,000 | -60.3% | 732,967 | -7.2% | 0.00% | -50.0% |
Q3 2018 | $8,132,000 | -31.8% | 789,467 | -4.9% | 0.00% | -33.3% |
Q2 2018 | $11,916,000 | +29.2% | 830,364 | 0.0% | 0.00% | +50.0% |
Q1 2018 | $9,225,000 | – | 830,364 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Atlas Venture Associates IX, LLC | 3,361,535 | $37,347,000 | 28.23% |
Novo Holdings A/S | 665,181 | $31,669,000 | 3.97% |
New Leaf Venture Partners, L.L.C. | 550,000 | $6,111,000 | 3.30% |
SECTORAL ASSET MANAGEMENT INC | 1,081,545 | $12,016,000 | 1.32% |
SABBY MANAGEMENT, LLC | 1,106,445 | $12,292,000 | 0.73% |
Monashee Investment Management LLC | 175,000 | $1,944,000 | 0.54% |
DC Investments Management, LLC | 35,524 | $395,000 | 0.26% |
Athanor Capital, LP | 22,300 | $248,000 | 0.12% |
PLATINUM INVESTMENT MANAGEMENT LTD | 225,000 | $2,499,000 | 0.07% |
Schonfeld Strategic Advisors LLC | 73,000 | $811,000 | 0.06% |